c-MYC Antikörper (FITC)
-
- Target Alle c-MYC (MYC) Antikörper anzeigen
- c-MYC (MYC) (Myc Proto-Oncogene protein (MYC))
- Reaktivität
- Bitte anfragen
-
Wirt
-
Huhn
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser c-MYC Antikörper ist konjugiert mit FITC
-
Applikation
- Western Blotting (WB), ELISA
- Top Product
- Discover our top product MYC Primärantikörper
-
-
- Applikationshinweise
- Western blot: Use at 1:1,000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS, pH 7.2 with 0.2% BSA and 0.1% sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
-
- Target
- c-MYC (MYC) (Myc Proto-Oncogene protein (MYC))
- Andere Bezeichnung
- C-Myc (MYC Produkte)
- Hintergrund
- Chickens were immunized with C-Myc peptide conjugated with KLH. After multiple immunizations in Freund's adjuvant, eggs were collected. Antibodies were immunoaffinity- purified using the peptide immobilized on a solid phase. The antibodies were conjugated with Fluorescein Isothiocyanate (FITC). Specification: Prior to conjugation, the antibodies were analyzed by ELISA and Western blot analyses. The molar F/P ratio is 5.6.
- Pathways
- p53 Signalweg, Zellzyklus, Sensory Perception of Sound, Transition Metal Ion Homeostasis, Mitotic G1-G1/S Phases, Positive Regulation of Endopeptidase Activity, Regulation of Carbohydrate Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus, Warburg Effekt
-